# OnCo record halda-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/halda-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "halda-therapeutics" ;
  schema:name "Halda Therapeutics"@en ;
  schema:description "Halda Therapeutics invented a new kind of oral cancer drug that links a protein found only in tumour cells to a protein cells need to survive, killing the cancer cell. Johnson & Johnson bought the company for 3.05 billion US dollars in 2025."@en ;
  schema:url <https://onco.cc/companies/halda-therapeutics/>, <https://www.haldatx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.haldatx.com/>, <https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-halda-therapeutics-and-its-novel-platform-to-revolutionize-cancer-treatment-and-enable-next-generation-oral-therapies>, <https://www.sec.gov/Archives/edgar/data/200406/000020040626000002/a2025q4exhibit991.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> .